PHP
MORF

Parkman Healthcare Partners’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Parkman Healthcare Partners’s Portfolio MORF Stock Details MORF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-75,000
Closed -$1.72M – 110
2023
Q3 		$1.72M Buy
+75,000
New +$3.94M 0.31% 83

Other funds holding MORF

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parkman Healthcare Partners's MORF Position: Q4 2023 in Review

Parkman Healthcare Partners sold out of Morphic Holding, Inc. Common Stock (MORF) in Q4 2023, closing a stake of 75,000 shares — an estimated $1.72M sold.

Parkman Healthcare Partners first reported a position in MORF in Q3 2023 and held it in 1 quarter. The position peaked at $1.72M in Q3 2023. 135 funds tracked by Wall St. Rank hold MORF as of Q4 2023.

  • Parkman Healthcare Partners reported no remaining Morphic Holding, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Parkman Healthcare Partners sold 75,000 Morphic Holding, Inc. Common Stock shares in Q4 2023, an estimated $1.72M.
  • Parkman Healthcare Partners first reported a position in Morphic Holding, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Parkman Healthcare Partners's Morphic Holding, Inc. Common Stock position peaked at $1.72M in Q3 2023.
  • 135 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q4 2023.

Based on Parkman Healthcare Partners's 13F filing for Q4 2023, filed 14 Feb 2024.